CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Long-term Combination Therapy With α-Blockers and 5α-Reductase Inhibitors in Benign Prostatic Hyperplasia: Patient Adherence and Causes of Withdrawal From Medication
Hueih Ling Ong, Chun-Hou Liao, Hann-Chorng Kuo
Int Neurourol J. 2016;20(4):356-362.   Published online 2016 December 26
DOI: https://doi.org/10.5213/inj.1632526.263

Excel Download

Long-term Combination Therapy With α-Blockers and 5α-Reductase Inhibitors in Benign Prostatic Hyperplasia: Patient Adherence and Causes of Withdrawal From Medication
International Neurourology Journal. 2016;20(4):356-362   Crossref logo
Link1 Link2 Link3

Effect of Shifting from Combination Therapy to Monotherapy of α-Blockers or 5α-Reductase Inhibitors on Prostate Volume and Symptoms in Patients with Benign Prostatic Hyperplasia
Korean Journal of Urology. 2011;52(10):681   Crossref logo
Link1

Long-term Sustained Improvement in Symptoms of Benign Prostatic Hyperplasia With the Dual 5α-Reductase Inhibitor Dutasteride: Results of 4-Year Studies
Yearbook of Urology. 2006;2006:102-103   Crossref logo
Link1 Link2

Inhibitors of steroid 5α-reductase in benign prostatic hyperplasia, male pattern baldness and acne
Trends in Pharmacological Sciences. 1989;10(12):491-495   Crossref logo
Link1 Link2

5α-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction
Best Practice & Research Clinical Endocrinology & Metabolism. 2008;22(2):389-402   Crossref logo
Link1 Link2

How Much Does Benign Prostatic Hyperplasia Cost? A Budget Impact Analysis on Italian Patients Treated with 5α-Reductase Inhibitors
Value in Health. 2013;16(7):A332   Crossref logo
Link1 Link2

Active Surveillance of Very-low-risk Prostate Cancer in the Setting of Active Treatment of Benign Prostatic Hyperplasia With 5α-reductase Inhibitors
Yearbook of Urology. 2013;2013:147-148   Crossref logo
Link1 Link2

Medical Treatment of Benign Prostatic Hyperplasia: 5α-Reductase Inhibitors and α-Adrenergic Antagonists
Mayo Clinic Proceedings. 1993;68(7):670-679   Crossref logo
Link1 Link2

Therapeutic options in the treatment of benign prostatic hyperplasia
Patient Preference and Adherence. 2009;213   Crossref logo
Link1

Medical therapy for clinical benign prostatic hyperplasia: α1 Antagonists, 5α reductase inhibitors and their combination
Asian Journal of Urology. 2017;4(3):185-190   Crossref logo
Link1 Link2